One study found that Omicron reduced the Pfizer COVID-19 vaccine's protectiveness after two doses. Image: REUTERS/Eduardo Munoz
Explore and monitor how COVID-19 is affecting economies, industries and global issues
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:
What is the World Economic Forum doing about access to vaccines?
License and Republishing
The views expressed in this article are those of the author alone and not the World Economic Forum.
The Agenda Weekly
A weekly update of the most important issues driving the global agenda